NIAID established the Regional Centers of Excellence in Biodefense and Emerging Infectious Diseases (RCE) program in 2003 to support research focused on countering threats from bioterror agents and emerging infectious diseases. Initial funding established 8 RCEs, with two more funded in 2005. Each Center included a consortium of universities and research institutions within a specific geographical region. In 2009, funding for the 10 original Centers was renewed and a new Center was established.
The RCE program built and maintained a strong scientific infrastructure supporting multifaceted research and development activities that promoted scientific discovery and translational research focused on creating next generation therapeutics, vaccines, and diagnostics. Research supported by the RCEs spanned a broad range of biodefense and emerging infectious disease topics including
The RCE program ended in 2014. That same year NIAID established the Centers of Excellence for Translational Research (CETR) to build on the work of previous NIAID-supported research and development programs, including the RCEs.
Last Updated October 23, 2014